Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Phase II Trial of Trametinib with Docetaxel in Patients with Kras Mutation Positive Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease Following One or Two Prior Systemic TherapiesCIRB: Adult CIRB - Late Phase EmphasisLead Group: SWOGStatus: ActiveReview Status: Available to Open
